Epigenetics is a term used to describe stable alterations in gene expression that are not associated with changes to the DNA
sequence. 1 This definition uses "stable" in the context of mitotic division (somatic cells) and not necessarily to suggest that these changes are heritable across animal generations (germ line transmission), an idea that is controversial due to prenatal epigenetic reprogramming, but may indeed be plausible. In recent years, a striking amount of evidence has accumulated to suggest that changes to the epigenetic landscape play an important role in the pathogenesis of a number of diseases, including type 2 diabetes (T2D). [2] [3] [4] [5] DNA methylation involves the addition of a methyl group mainly to the 5th position on the pyrimidine ring of cytosines that occur as the dinucleotide, CpG. 6 This biochemical process is catalyzed by DNA methyltransferases (DNMTs). Most CpGs in the human genome are methylated; unmethylated CpG dinucleotides are found in clusters called CpG islands, most commonly located at the 5' region of genes. 7 Hypermethylation of DNA, particularly at CpG islands, serves as a major transcriptional silencing mechanism. In general, this occurs as a result of recruitment of methyl-domain binding proteins, histone deacetylase (HDAC), and blockage of the binding sites of other proteins. 6 Methylated cytosines may further be modified by addition of a hydroxyl group by Ten-11 translocation-2, a methyl-cytosine dioxygenase enzyme; the role of hydroxymethylated cytosines in gene regulation is still unclear. 8 DNA is packaged as nucleosomes consisting of DNA strands (147 bp) wrapped around an octamer of histone proteins (two each of H2A, H2B, H3 and H4), and covalent modifications that influence this packaging have a profound influence on transcriptional activity. Exposed amino acid residues that protrude from the N-terminal region of histones are subject to a number of covalent modifications such as acetylation, methylation and phosphorylation, to name a few. 9 Lysine acetylation and methylation with imperfect sequence complementary to the 3' untranslated region of the target mRNA; binding to target mRNAs leads to RNA degradation or blocking of translation. 14, 15 It is estimated that up to 60% of human genes are subject to regulation by miRNAs and that miRNAs are involved in cell proliferation, differentiation and apoptosis. 16, 17 From a biochemical standpoint, the connection between nutrition and epigenetic modifications is obvious. Methyl metabolism in the body is central to a number of biological pathways and dietary deficiencies or excesses in methyl donors and cofactors used in enzymatic reactions may lead to global changes in DNA and/or histone methylation patterns. The primary methyl donor, S-adenosyl methionine (SAM), is biosynthesized from amino acid l-methionine ( Fig. 1 ; based on refs. 18 and 19) . The regeneration of SAM from S-adenosyl homocysteine (SAH) also relies upon the presence of several nutrients that serve as cofactors or intermediates, including folate, betaine, choline, zinc, as well as vitamins B 2 , B 6 and B 12 . 18, 19 The SAH is a negative feedback regulator of methyltransferase activity, hence its accumulation can inhibit DNA or histone amino acid methylation reactions. 18 Jirtle's research group pioneered the use of mice that carry the Avy allele (agouti viable yellow) of the murine agouti gene as a model for studying effects of methyl donor supplementation during maternal gestation on epigenetic modifications in offspring. 20 This allele is a metastable epiallele, meaning that it can be variably and reversibly modified by epigenetic marks, resulting in variety of phenotypes among genetically identical cells. The methylation status of a transposable element containing a constitutive promoter, inserted upstream of the agouti gene (Avy allele), influences whether or not the agouti gene is turned on. The timing and level of agouti expression then determines coat color in mice. When the gene is constitutively turned on due to hypomethylation of the transposable element, mice have a yellow coat color and are predisposed to obesity and tumorigenesis. Normal regulation of gene expression (hypermethylation of transposable element), on the other hand, leads to transient expression of agouti (tissue-and hair-cycle-specific), and as a result, the typical brown "wild type" coat color with a sub-apical shaft of yellow. Depending on the nutritional status of the dam, offspring display a range of coat color phenotypes. Jirtle's group demonstrated in a number of studies, that methyl donor supplementation during gestation in mice that carry the Avy allele alters are examples of histone modifications that regulate gene activity. Histone acetyltransferases (HATs) and HDACs are enzymes that regulate the acetylation and deacetylation of histones and other proteins, respectively. [9] [10] [11] HDACs interact with DNA via adaptor co-repressor proteins (e.g., mSin3). Acetylation of N-terminal lysine residues on H3 and H4 by HATs is generally associated with active chromatin, whereas deacetylation by HDACs is associated with transcriptional repression. 9, 11, 12 Methylation of various histone lysine residues by histone methyltransferases (HMTs) may enhance or repress transcription depending on the location and number of methyl groups. 13 Hence, one can surmise that due to the number of potential covalent modifications and number of modification sites on histones, teasing apart the network of mutually reinforcing epigenetic marks into a chronological series of events can be quite difficult.
In addition to biochemical modifications to DNA and histone proteins, gene expression may also be regulated by microRNAs (miRNAs), which are 20-30 nucleotide non-coding RNAs Figure 1 . Methyl metabolism overview and influence of dietary factors. Methyl metabolism is controlled by availability of key nutrients. The 5th position of the pyrimidine ring of cytosine located in the context of CpG dinucleotides is methylated by DNA methyltransferase. SAM is the primary methyl donor of methylation reactions and is concomitantly converted into SAH. SAH inhibits DNMT as a negative feedback mechanism. SAH is converted into homocysteine, which can then be converted into methionine. The conversion of homocysteine to methionine is highly dependent on several nutrients, including choline and betaine and Zn and B6, or folic acid, and B2, B6 and B12, depending upon which pathway is utilized to provide a methyl group to generate methionine. Elevation of homocysteine has a deleterious effect in the body. Abbreviations: DNMT, DNA methyltransferase; SAM, S-Adenosyl l-methionine; SAH, S-Adenosyl homocysteine; SAHH, Sadenosyl-homocysteine hydrolase; CBS, cystathionine-b-synthase; Cys, cysteine; GSH, glutathione; B6, Vitamin B6; Zn, zinc; BHMT, betaine-homocysteine S-methyltransferase; B2, Vitamin B2; B12, Vitamin B12; CH3-THF; 5-methyltetrahydrofolate; MTHFR, methylenetetrahydrofolate reductase; 5,10-Ch2 THF, 5,10-methylenetetrahydrofolate; GHMT, glycine hydroxymethyltransferase; Gly, glycine; Ser, serine; DHF, dihydrofolate; DMG, dimethylglycine; MAT, methionine adenosyltransferase.
using whole genome association studies to search for single nucleotide polymorphisms (SNPs) that confer a high risk for T2D or are highly associated with T2D in subpopulations of humans. 36, 37 While at least 38 individual loci that confer risk have been identified, 38 accounting for more than 300 journal articles, 39 the list of involved genes differs in populations across various geographical regions 40 and there are still many risk factors to be identified that can further explain predisposition to and pathogenesis of T2D. 37 However, it has become increasingly clear that environmental factors, combined with genetic predisposition, play a more important role in conferring risk for metabolic diseases. 39 Wren et al. 36 evaluated 25 SNP studies and observed that ten of the identified SNPs occurred in the promoter region of genes and, within those ten, seven SNPs altered the number of CpG dinucleotides in the promoter-a very intriguing discovery. Furthermore, three of those seven genes were C-reactive protein and pro-inflammatory cytokines resistin and interleukin-6, all of which are highly associated with obesity, insulin resistance and T2D. [41] [42] [43] [44] [45] Thus, changes in regulation of gene expression due to alterations in the number of methylation sites on the promoter could be a mechanism that contributes to the T2D phenotype. Most of the genes associated with T2D risk are related to β-cell function, as reviewed in reference 38, suggesting that alterations in insulin production and secretion are central to the pathogenesis of the disease.
The risk for developing T2D increases with advancing age. 46 Errors in DNA methylation are known to occur and accumulate with age, potentially contributing to a variety of age-related diseases such as cancer and T2D. 5 There are a myriad of metabolic changes that occur during the pathogenesis of T2D that support a role for epigenetics in the advancement of chronic diseases. Changes in methyl metabolism, including increased levels of homocysteine, consumption of sulfur-poor diets leading to increased siphoning of methionine to the formation of cysteine, and polymorphisms in methylene tetrahydrofolate reductase all predispose individuals to T2D. 36 Wren et al. 36 used an innovative data mining approach to search for a potential link between epigenetics and pathogenesis of T2D based on a search of Medline records. They found that methylation and chromatin were among the top-five ranked items linked to T2D, based on common shared relationships. These shared relationships include obesity, fatty acids, maternal influence, methylene tetrahydrofolate reductase, cytokines, homocysteine, variable severity and late-onset. Wren et al. 36 went a step further and proposed a model for the pathogenesis of T2D based on these findings. They suggested that increased production of short-chain fatty acids as by-products of long-chain fatty acids leads to changes in DNA methylation that cause promoter hypomethylation and dysregulation of pro-inflammatory cytokines.
The role of miRNAs in pancreas development and β-cell function. miRNAs are essential for normal pancreas development and are implicated in diabetes. 47 A recent review highlighted studies in which expression of a number of different miRNAs is altered in various tissues during the development of diabetes. 48 Conditional deletion of Dicer1, a gene that encodes a pre-miRNA processing enzyme, in the mouse pancreas at embryo day 9.5, coat color distribution in the offspring, and that coat color is associated with methylation status of the transposable element upstream of the agouti gene. [20] [21] [22] These data collectively demonstrated that diet may influence animal health through direct changes in epigenetic regulation of gene expression and this effect may be heritable as they persisted through the F 2 generation.
Epigenetic modifications play a number of key roles in animal growth and development. Epigenetic marks confer tissue specificity to gene expression and are responsible for silencing transposable elements in the genome. 23 They are important in X-chromosome inactivation 24 and genomic imprinting. 25 Genomic imprinting is a phenomenon observed in a small subset of genes (~1% of the genome) whereby only one parental allele for a gene is expressed, most commonly the paternal allele. This mode of gene expression is explained by the "parental conflict hypothesis" which states that from an evolutionary standpoint, investment of resources in one offspring by the mother diverts resources that could be invested in other offspring. Because the mother is genetically related to all offspring, there is a driving force for resource allocation that promotes survival of all progeny. The father, on the other hand, would wish to maximize investment in genetically related offspring to ensure that genes are passed on. Thus, genes that pull resources from the mother tend to be silenced on the maternal allele and expressed from the paternal allele. A perfect example of this is the paternally expressed insulin-like growth factor 2 (IGF-2), an important fetal growth factor. Interestingly, the IGF-2 receptor, which plays a scavenging role in targeting IGF-2 for destruction, is expressed only from the maternal allele. Genomic imprinting is important in the context of metabolic disorders since those genes involved in energy metabolism are vulnerable to epigenetic plasticity and thus functional changes. Most of the genes modulated by diet though, are not subject to genomic imprinting.
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Genetic and Epigenetic Risk Factors for T2D
It is estimated that in the US alone, there are at least 25 million, or 7.8% of people, that presently suffer from diabetes and 57 million people have pre-diabetes. 27 While the availability of novel drugs, techniques and surgical intervention has improved the survival rate of individuals with diabetes, the prevalence of diabetes is still rising worldwide, with the number of people with diabetes projected to double by 2025. 28 In both type 1 and T2D, loss of β-cell mass and function through apoptosis is central to the deterioration of glycemic control over time. 29 While peripheral insulin resistance is common during obesity and aging in mice and people, progression to T2D is largely due to insulin secretory dysfunction and significant apoptosis of functional β-cells, [29] [30] [31] [32] [33] leading to an inability to compensate for insulin resistance. Indeed, those with T2D always manifest increased β-cell apoptosis and reduced β-cell mass. 31, 32, 34 As such, further research advances in understanding mechanisms of β-cell dysfunction and apoptosis may help design strategies to promote β-cell survival, mass and function, thereby preventing and treating T2D. 35 Much of the work conducted to unravel the complexity surrounding the pathogenesis of T2D utilized a genetic approach was not one of the altered miRNAs. The miRNA expression was influenced by palmitate but not by two unsaturated fatty acids, oleate and linoleate, and effects of palmitate on gene expression were not apparent until 72 h, consistent with the theory that chronic exposure to saturated fatty acids leads to cellular dysfunction. 16 Overexpression of miR34a and miR146 amplified palmitate-induced apoptosis, while knockdown blunted the effects of lipotoxicity. 16 Similarly, miRNA profiling after chronic exposure of MIN6 cells to interleukin-1β (IL-1β) or a mixture of IL-1β, tumor necrosis factor-α and interferon-γ for 24 h demonstrated that while most miRNAs were unchanged, there was an increase in the expression of miR21, miR34a and miR146. 60 miR146a expression is regulated by NF-κB, a transcription factor that plays a role in cytokine-mediated signaling. 60 Effects of inflammation-induced β-cell dysfunction on miRNA expression were confirmed with a T1D mouse model, whereby miRNA profiling in 4-and 8-week-old (spontaneously diabetic at this age) NOD mice islets revealed an upregulation in miR21, miR34a, miR146a/b, and miR29a/b/c in β-cells from islets of 8-weekold mice. 61 Overexpression of miR29a/b/c in MIN6 cells was associated with decreased pro-insulin expression and GSIS and increased apoptosis.
61 miR29a and miR29b target monocarboxylate transporter 1, which leads to reduced insulin release. 62 Onecut2, a target of miR29, was decreased by miR29 overexpression, leading to increased expression of granuphilin, a negative regulator of exocytosis that interacts with proteins involved in vesicular transport, 63 providing another link between miR29 and the pathway of insulin granule exocytosis. The miR9 also targets Onecut-2 and affects insulin secretion through a similar pathway. 64 Recently, Ramachandran et al., showed that miR9 also targets the 3'UTR of Sirtuin 1, a NAD-dependent protein acetylase. 65 Thus, groups of miRNAs have been identified that play a role in pancreas development (cell lineage specification and differentiation) as well as mature β-cell function (insulin expression, secretion and signaling). 66 The studies described herein are relevant to the human condition; miR9, miR29a, miR30d, miR34a, miR124a, miR146a and miR375 were elevated in the serum of T2D patients, 67 and as discussed above, appear to be involved in β-cell function and the pathogenesis of T2D. With inflammation, hyperglycemia and lipotoxicity as key factors in the pathogenesis of T2D and predisposing factors to β-cell dysfunction, miRNAs may provide a link between altered fat metabolism (e.g., increased ceramide signaling), chronic hyperglycemia, inflammation (increased pro-inflammatory cytokine-induced signaling) and β-cell apoptosis. 54 
Perturbations to β-cell Development during Embryonic Programming and the Risk for the Development of T2D
There is mounting evidence that nutritional or environmental insults during in utero development may have effects on metabolic adaptation that persist throughout life and may even be transmitted to subsequent generations. 68 For example, results from studies that stemmed from pregnancies during the Dutch impaired development of the endocrine cell lineages, α-and β-cells. 49 While deletion during embryogenesis affects pancreas endocrine cell development, deletion during adulthood affects mature β-cell function. Deletion of Dicer1 in adult mice led to a substantial decrease in insulin expression and secretion, leading to a diabetic phenotype. 50 The authors suggested that there is a combined function of multiple miRNAs to regulate β-cell function as knockdown of individual miRNAs (miR182, miR24 1-3, miR148 a-b, and miR26 a1, a2 and b) showed minor effects. 50 As discussed below, in addition to there being deleterious effects of knocking down miRNAs on β-cell function, hyperglycemia and lipotoxicity have profound effects on miRNA expression, demonstrating that miRNAs are dynamically regulated in response to environmental conditions in the β-cells.
In a landmark study reported in 2004, Poy et al. identified 67 different miRNA species in mouse insulinoma 6 (MIN6) cells, of which miRNA 375 (miR375) was the most abundant. The miR375 is enriched in pancreatic islets, not detected in other tissue types, 47 and its deletion in mice leads to hyperglycemia and a reduction in the number of β-cells, 51 and impaired islet development in zebra fish, 52 suggesting that its presence is critical for normal programming of β-cells and maintenance of glucose homeostasis. Knockdown of miR375 in MIN6 cells led to enhanced glucose-stimulated insulin secretion (GSIS), while overexpression led to a 40% reduction in insulin secretion. 47, 53 The mechanism of how it reduces insulin secretion is partly understood, as it was shown to target the myotrophin (Mtpn) mRNA, which encodes a protein that is involved in actin depolymerization and vesicle fusion and plays a role in the late stage of insulin granule exocytosis. 53 Li et al. 54 observed that knockdown of miR375 protected NIT-1 β-cells (derived from the NOD mouse strain) from palmitate-induced apoptosis. Palmitate treatment was associated with a downregulation in myotrophin protein levels, which was prevented by a knockdown of miRr375. 54 Through a computational approach, it was predicted that miR375 also targets 3-phosphoinositide dependent protein kinase-1 (PDK1), a kinase important in the activation of AKT/PKB, a key component of the insulin signaling pathway. 55 Subsequent functional assays showed that overexpression of miR375 in INS-1E cells led to a 40% reduction in PDK1 protein abundance, with no effect on its mRNA, suggesting that miR375 blocks translation rather than inducing target mRNA degradation. 55 The miR124a is co-expressed with miR375, and also targets myotropin 56 and PDK1, 55 suggestive of coordinate regulation. The miR124a also targets the transcription factor FOXA2, 57, 58 which plays a role in β-cell differentiation.
In Goto-Kakizaki rats, a spontaneous model of T2D, 30 miRNAs were identified as differentially expressed in islets as compared with control Wistar rats, 24 of which were upregulated in the diabetic islets. 59 Lovis et al. 16 performed miRNA profiling on MIN6B1 β-cells grown in the presence or absence of excess palmitate for 3 d and observed that out of 132 miRNAs that were expressed in these cells, several were upregulated in response to palmitate treatment, including miR34a and miR146, both in MIN6B1 cells and freshly isolated rat islets, as well as nontreated diabetic (db/db) mouse islets.
16 Surprisingly, miR375
this period can vastly alter the course of programming and lead to changes that persist until adulthood. Both maternal over-and under-nutrition during pregnancy, as well as gestational diabetes are associated with a heightened risk for the progeny to develop diabetes later in life. 68 One of the best understood examples of epigenetic changes during gestational nutrient restriction, leading to diabetes in the offspring is the sequence of events that lead to silencing of the pancreatic and duodenal homeobox-1 (Pdx-1) gene in β-cells.
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Pdx1 is a transcription factor that is essential for pancreas development, β-cell differentiation, insulin production and glucose homeostasis by regulating transcription of multiple genes such as insulin, glucose transporter (GLUT)2 and glucokinase (GK). 80 Homozygous mutations in Pdx-1 lead to pancreatic agenesis. 2 Heterozygous mutations, while leading to a normal pancreatic β-cell mass, are highly associated with insulin secretory defects and maturity-onset of T2D in young individuals. 2 Consistently, Pdx-1 reduction also causes islet β-cell dysfunction and impairs glucose homeostasis in rodents. 81 The expression of Pdx-1 in IUGR rats is downregulated by 50% within 24 h after onset of IUGR and continues to decline to almost negligible levels after birth into adulthood, leading to the progressive reduction in β-cell mass, defects in insulin secretion, insulin resistance, and the development of T2D at 15-26 weeks of age. 82 However, it is unclear how nutritional insults during fetal development leads to reduction of Pdx-1 expression, aberrant programming of the endocrine pancreas, and diabetes development in adult offspring. Park et al. 77 conducted a comprehensive evaluation of the developmental sequence of epigenetic events at the Pdx-1 promoter using the IUGR diabetic rat model. There was no Pdx-1 promoter methylation at the fetal stage after IUGR or at 2 weeks of age, but by 6 mo of age the CpG islands were heavily methylated in the diabetic rats, paralleling the pattern of DNMT binding. A reduction in acetylation of H3 and H4, however, was readily detectable at the fetal stage after IUGR, as was increased binding of the HDAC/mSin3 co-repressor complex. At 2 weeks of age, there were also changes in histone methylation consistent with the progressive silencing of Pdx-1. These data suggest that changes in HAT/HDAC activity may be the early events responsible for the progressive epigenetic silencing of Pdx-1 ultimately leading to diabetes, whereas DNMT activity is a secondary event that essentially "locks" the Pdx-1 promoter into a repressed state. Interestingly, when IUGR islets from 2-weekold rats were treated with a combination of HDAC inhibitor (trichostatin-A) and DNMT inhibitor (5'-Aza-2-deoxycytidine), Pdx-1 mRNA abundance was restored.
It was recently demonstrated that exendin-4, a glucagon-like peptide-1 analog, when administered to 1 d old IUGR rats for 6 d, could prevent the series of epigenetic events that lead to Pdx-1 silencing after birth, thus preventing diabetes. 83 Exendin-4 treatment was associated with enhanced recruitment of a critical transcription factor, upstream stimulatory factor-1 (USF-1), and a protein with HAT activity, p300/CBP associated factor, to the proximal Pdx-1 promoter. In agreement with the earlier study, alterations in HAT activity and USF-1 binding are the early events that lead to progressive Pdx-1 transcriptional famine showed that malnutrition during pregnancy led to metabolic effects in the offspring that persisted into adulthood. 69 Males who were subjected to famine during the first trimester of pregnancy were more likely to be obese than those who experienced under-nutrition during the last trimester of pregnancy. In the past few years, these epidemiological studies have been complemented with molecular analyses and there are now data that correlate metabolic differences with epigenetic changes. Individuals with pre-natal exposure to the 1944-1945 Dutch Famine displayed, in addition to impaired glucose tolerance, reduced methylation of the IGF-2 gene, as well as a number of other genes, six decades later, as compared with their same-gender, un-exposed siblings. 70, 71 One of the explanations for the effects of under-nutrition during pregnancy on post-natal health of the offspring is the "thrifty phenotype" or "Barker" hypothesis, first championed by Hales and Barker in 1992. 72 According to this theory, nutritional deprivation during pregnancy causes organ development to adapt to the current nutritional conditions such that there is "nutritional thrift," assuming that post-natal nutritional conditions will be similar. After birth and into adulthood, consumption of an energy-dense diet exceeds the metabolic capacity of organs (e.g., the endocrine pancreas) and the individual becomes susceptible to metabolic disease.
Results from a recent study show a correlation between methylation status of the retinoid X receptor-α (RXRα) promoter and childhood adiposity and an indirect correlation with carbohydrate intake during early pregnancy. 73 This was particularly interesting as RXRα dimerizes with peroxisome proliferator-activated receptor (PPAR) proteins and regulates lipid and carbohydrate metabolism in the body. Nutritional status during adolescence may also influence the predisposition for metabolic disease in later generations. Excess caloric intake by children during their slow growth period of childhood was linked to a heightened risk for T2D-related mortality in their grandchildren. 74 Maternal protein restriction, 75 high-fat diets, 76 intrauterine growth retardation (IUGR) 77 and methyl donor restriction are a few of the models illustrating that early nutritional insults have long-lasting effects in the offspring that increase the likelihood of developing chronic diseases such as T2D. 78 Maternal protein restriction during pregnancy in rats, for example, leads to hypomethylation of specific genes in the liver of the pups, including glucocorticoid receptor and PPARα. 75 These reductions in promoter methylation status were associated with increases in mRNA abundance. Since these pups are predisposed to metabolic disorders post-weaning, these changes in gene expression may mediate metabolic changes that lead to disorders later in life. Maternal effects on fetal growth are thought to be due to changes in epigenetic programming at critical stages of development. There are multiple periods during which the epigenome is particularly susceptible to regulation including gestation, the neonatal period, puberty and old-age. 21 During fetal development there is rapid growth, cell replication, and differentiation and functional maturation of organs, as well as dynamic changes in epigenetic programming, including genome-wide erasures and re-establishment of chromatin marks. 79 Nutritional perturbations during Reductions in menin led to reductions in promoter occupancy at these genes and a subsequent increase in cell proliferation, providing a plausible mechanism for pregnancy-induced changes in islet expansion. Infusion of prolactin, a pregnancy hormone, downregulated Men1 expression and enhanced proliferation of β-cells. Glucose infusion led to downregulation of Men1, providing a clue as to how glucose is able to stimulate β-cell proliferation. 94 Insulin expression may also be altered by epigenetic modifications. The insulin promoter is regulated by DNA methylation, with hypomethylation observed in β-cells and hypermethylation in other cells. 95 Chromatin immunoprecipitation experiments revealed that increased methylation at CpG sites in the insulin promoter was associated with increased binding of methyl CpG binding protein 2 and reduced binding of transcription factors associated with active promoters. 95 Expression of the insulin gene is inversely correlated with the degree of methylation in a CpG site-specific manner. Patients with T2D displayed enhanced methylation at 4 CpG (-234, -180, -102 and +63 relative to TSS) sites on the insulin promoter in islets, as compared with islets from non-diabetic patients, and methylation status of nine additional CpG sites were inversely correlated with insulin mRNA abundance. 96 Interestingly, when β-cell lines were exposed to high glucose conditions for 3 d, methylation status of the insulin promoter increased. 96 In the same study, authors found no relationship between aging and DNA methylation status, but did see a correlation between obesity and DNA methylation, acknowledging that sample size was a limiting factor in their analyses. 96 Thus, it is difficult to ascertain if changes in DNA methylation at the insulin promoter are a result of age, BMI, hyperglycemia or a combination of these factors leading to dysfunction of pancreatic β-cells.
Why certain genes are more vulnerable to DNA methylation and epigenetic silencing as compared with others is still unknown. Feltus et al. 7 conducted a comprehensive study to identify methylation-sensitive and methylation-resistant genes in order to identify patterns that may elucidate the mechanism underlying methylation-sensitivity (i.e., DNA sequence patterns). Using DNMT1-overexpressing human cell lines, they observed that out of 1,749 CpG islands, almost 80% were resistant to DNA methylation and only 4% were described as being highly susceptible to methylation. Interestingly, islands that were consistently hypermethylated were associated with genes that exhibited restricted expression in the body, particularly homeobox genes such as Cdx2 and Pdx1. Methylation-resistant islands were associated with genes containing broader, more constitutive expression in the body. The authors suggested that while DNMT1 overexpression led to genome-wide increases in promoter methylation patterns, it is the local promoter environment that influences gene-specific sensitivity to methylation. Hence, these results may explain why changes in activity of chromatin-modifying enzymes only affect a small subset of genes. In transgenic mice lacking the DNMT1 gene, β-cells trans-differentiated into α-cells and this was correlated with hypomethylation of Arx1, a homeobox gene. 97 Removal of DNMT1 did not lead to large-scale changes in methylation status of genes, demonstrating that there was a localized effect of changes in DNA silencing. These data demonstrate that it is important to elucidate the sequence of events that occur during the transition from an active to silenced state in order to effectively develop a preventative treatment strategy, while it is imperative to understand the repertoire of epigenetic modifications that define a silenced state for a particular gene. 84 
Epigenetic Changes and β-Cell Function
As above discussed, loss of β-cell mass and function are central to the development of both type 1 diabetes (T1D) and T2D. 29 Importantly, β-cells have the potential to regenerate after tissue injury and repair or after onset of diabetes. 85, 86 Indeed, recent findings demonstrated that proliferation of pre-existing β-cells is the major mechanism for regeneration of murine islets both under physiological and injury conditions, 87 suggesting that pancreatic β-cell proliferation plays an important role in islet adaption to increased insulin or metabolic demands. Pancreatic β-cell mass expansion is known to occur during pregnancy and under certain pathophysiological conditions such as injury, obesity and cancer. 88 Insulin resistance, the condition preceding the onset of diabetes, is associated with compensatory insulin release as an adaptation by islets in response to increased insulin demands. Islet adaptation may be associated with either enhanced β-cell mass or increased functionality of pre-existing β-cells. While a large body of literature from animal studies showed that promotion of β-cell mass is a promising strategy to prevent and treat diabetes, 29, 30, 35, 85, 86, 89 recent studies indicated that the capacity of β-cell regeneration is very limited in middle-aged and older mice, 90, 91 which indicates that it is still challenging to develop β-cell regeneration-based therapies for human T2D that occurs mostly in middle-aged and older individuals with manifestation of reduced β-cell mass. 34 Therefore, elucidating the underlying mechanisms leading to enhanced β-cell mass under some conditions and reductions in β-cell proliferation during aging and diabetes, may lead to identification of novel therapeutic targets.
In rodents, islet mass increases up to 4-fold during pregnancy and returns to normal size after parturition, demonstrating the enormous plasticity of this tissue under certain physiological conditions. 92, 93 As β-cell expansion during pregnancy mimics the hyperplasia that occurs in certain types of endocrine cancers, Karnik et al. 93 decided to evaluate expression of Men1, a gene that is mutated in multiple endocrine neoplasia type 1 (Men1), an autosomal dominant hereditary syndrome. Menin, the protein encoded by Men1, functions as part of a HMT complex containing mixed lineage leukemia protein, responsible for methylation of lysine residue 4 on histone protein 3 (H3K4), an epigenetic mark associated with actively transcribed genes (open chromatin). During pregnancy, Men1 is downregulated in pancreatic islets, leading to an increase in β-cell proliferation. 93 Karnik et al. 93 observed that β-cell proliferation and total mass were increased during pregnancy in C57Bl/6 mice and that the effect was blunted in transgenic pregnant mice expressing Men1. Moreover, they demonstrated that menin binds to the promoters of p27 Kip1 and p18 INK4C , genes that encode two cyclin-dependent kinase (CDK) inhibitors that prevent β-cell proliferation.
8-hydroxy-2-deoxyguanosine, the adjacent cytosine residues are more prone to be methylated. 46 Strand breaks in DNA can affect DNA methylation and DNA lesions can influence DNA-protein and protein-protein interactions, leading to aberrant patterns of DNA methylation. 46 The histones contain multiple lysine residues making them susceptible to the effects of oxidative stress as well. 79 Aging and the progression to insulin resistance and diabetes are associated with hindered oxidative capacity and mitochondrial function. 106, 107 Sedentary lifestyles may also promote biochemical changes in mitochondrial activity that has an epigenetic basis. Thus, the combination of inflammation, mitochondrial dysfunction and ROS production provides an attractive model for the pathogenesis of T2D and may explain the widespread alterations of epigenetic regulation of gene expression during the deterioration of glycemic control. 79 Inflammation of islets in the pancreas is referred to as insulitis, and in T2D is thought to be attributable to nutrient overload, leading to metabolic "exhaustion" in β-cells. 104 This can methyltransferase activity and that epigenetic regulation of gene expression is also important for maintaining cell differentiation.
The Roles of Oxidative Stress and Inflammation in Epigenetic Changes and β-Cell Destruction during the Pathogenesis of Diabetes
The role that epigenetic programming plays during the progression to T2D is still largely unknown but may be related to oxidative stress. Oxidative stress leads to damage in organelles, particularly the mitochondria and cellular proteins, lipids and nucleic acids. 79 In general, increased production of reactive oxygen species (ROS) from mitochondrial overstimulation and reactive nitrogen species from excess nitric oxide (NO) production in β-cells lead to a series of effects including inhibition of the electron transport chain leading to reduced energy production, DNA damage, and formation of advanced glycation end products (AGEs). 98 The β-cells are very much dependent on ATP production for GSIS and are vulnerable to the effects of excess amount of ROS because of inherently low expression of antioxidant enzymes. 79 Glucolipotoxicity, a term used to describe chronic elevated concentrations of glucose and free fatty acids, is thought to be a critical factor contributing to the pathogenesis of T2D. 99 Excess nutrient load induces a state of low-grade and chronic inflammation and cytokine production. 100 Fat tissue is the major source of inflammation, showing infiltration of macrophages and representing the primary source of cytokines in obese individuals. 100 Ceramide, a sphingolipid formed during lipid metabolism, may provide a link between excess circulating saturated fatty acids and inflammatory cytokines in cellular function, with both inhibiting various intermediates in the insulin signaling pathway. 101 Chronic hyperglycemia accelerates the rate of AGEs formation, which occurs through non-enzymatic glycosylation reactions between proteins and reducing sugars (Maillard reactions). 102 AGEs alter the activity of the modified protein and mediate signaling through receptors leading to tissue damage. 102 Binding to the receptors for AGE (RAGE) on β-cells leads to increased ROS and induction of apoptosis. 103 Reactive oxygen species enhance AGE-induced signaling, which activates pathways associated with inflammation. 104, 105 Thus, chronic exposure to elevated concentrations of nutrients, impairment in antioxidant status and activation of the inflammatory response are all inter-related and may contribute to cellular dysfunction and apoptosis (Fig. 2) .
Chromatin modifications are also vulnerable to oxidative stress. For example, if guanine is replaced with Figure 2 . Proposed model for β-cell dysfunction and apoptosis in the pathogenesis of type 2 diabetes. Obesity-associated inflammation leads to an increase in circulating levels of proinflammatory cytokines (e.g., TNFα and IL-1β). Insulin resistance is associated with hyperglycemia and increased lipolysis in white adipose tissue, leading to increases in circulating free saturated fatty acids. Chronic hyperglycemia leads to increased formation of advanced glycation end products (AGEs) that bind to cell surface receptors and have deleterious effects on cell function. The combined effects of excess nutrient load, cytokines and AGEs on β-cells leads to elevated production of reactive oxygen species (ROS) by the mitochondria, endoplasmic reticulum (ER) stress from increased metabolic burden, leading to epigenetic changes [increased recruitment of DNA methyltransferases (DNMT), histone deacetylase (HDAC)/msin3 complexes and increases in miRNA expression] that lead to reduced transcriptional activity of key β-cell genes, such as Pdx1 and insulin. Reductions in Pdx1 protein and insulin, combined with excess ROS lead to apoptosis and subsequent loss of glycemic control.
thermogenesis. In a different study, Jhdm2a-knockout mice displayed reduced expression of the insulin-dependent GLUT4 and genes associated with adipogenesis. 117 These mice also showed fasting-induced hypothermia and higher respiratory quotients. These observations fit well with the earlier study, whereby key genes associated with fat oxidation and energy production are downregulated as a function of deleting a key regulatory enzyme.
The PPARγ coactivator-1α (PGC-1α), which plays pivotal roles in the regulation of energy biogenesis and utilization in metabolic tissues 120 through co-activation of nuclear receptors, can be regulated by both genetic and epigenetic mechanisms. 121 Ling et al. 121 observed that PGC-1α expression was decreased and was paralleled by a 2-fold increase in methylation status of its promoter in the islets of diabetic patients as compared with controls, which was accompanied by impaired insulin secretory function of β-cells. This finding suggests that epigenetic mechanisms may be involved in regulation of metabolic gene expression, which directly or indirectly modulates β-cell function and insulin secretion in the islets.
GK, an enzyme that mediates the first step in glycolysis, the phosphorylation of glucose to glucose-6-phosphate, is a key glucose sensor in different cell types. It displays impaired hepatic activity in patients with diabetes 122 and promoter hypermethylation in rat models of high-fat diet-induced obesity 123 and diabetes. 124 Hypermethylation of DNA was associated with decreased gene expression of hepatic GK and in a cell culture model of steatosis, DNA methylation and effects on gene expression were reversed by treatment with 6-aza-2'-deoxycytidine. 123 In a recent study, researchers found that GK may be the key factor that stimulates regeneration of pancreatic β-cells in response to damage. 125 Mice that became hyperglycemic after 80% of their β-cells were destroyed showed a 6-fold increase in cell proliferation rate whereas normoglycemic mice with the same amount of β-cell destruction (normoglycemia maintained by islet transplantation) showed a 50% lower rate of proliferation. 125 Islet β-cell-specific deletion of GK led to hyperglycemia, hypoinsulinemia, a drop in rate of proliferation, and increase in the rate of apoptosis. Administration of a specific GK activator to isolated islets doubled the rate of β-cell replication. To further confirm that glycolysis activated β-cell replication, authors found that K ATP channel closure and membrane depolarization (events that lead to Ca 2+ influx and trigger exocytosis of insulin secretory granules) were critical for GK-induced β-cell replication. What determines whether glucose influx affects insulin secretion, proliferation, or apoptosis remains to be elicited. 125 It may be that antioxidant and/or metabolic and immune status of the cell are influenced by amount of glucose exposure, and these factors in turn influence the pathways mediated by glucose uptake. Chronic exposure to high concentrations of glucose, leading to oxidative stress and inflammation, may induce changes in the regulation of gene expression that converge on blunted insulin secretion and increased apoptosis. Epigenetic modifications may play an important role in determining how glucose influences β-cell function, and it would be interesting to evaluate how glucose affects regulation of Pdx1 expression in β-cells.
lead to a localized synthesis of cytokines, resulting in recruitment of immune cells to the site of production. Amylin, also known as islet amyloid polypeptide (IAPP), is secreted with insulin from β-cells and acts synergistically with insulin to control blood glucose levels. 108 Amyloid deposits (misfolded IAPP) are present in the islets of diabetic patients, are associated with fibrosis, which is known to be involved in inflammation, and IAPP was reported to stimulate release of IL-1β from bone-derived macrophages. 104, 109 Inflammatory markers such as acute phase proteins and cytokines (e.g., IL-1β and TNFα) are elevated in the bloodstream of obese, insulin resistant and diabetic patients (reviewed in ref. 104) . Glucolipotoxicity is associated with secretion of IL-1β and activation of the pro-apoptotic FAS receptor. 104 Free fatty acids may activate toll-like receptors, which leads to IL-1β production, and chronic high glucose exposure may lead to a series of events that culminate with the activation of caspase 1 and processing of mature IL-1β. 104 The cause of inflammation and association between inflammatory markers and onset of diabetes is still unclear. Although a rise in circulating levels of these markers may indicate activation of immune cells, it is difficult to pinpoint the tissue of origin and contribution of each tissue to total serum concentrations. 104 Adipose tissue and liver, being proportionally larger organs, may contribute a greater release of inflammatory factors into the bloodstream. Adipose tissue from obese individuals recruits and activates macrophages that secrete pro-inflammatory factors, including TNFα and inducible nitric oxide synthase (iNOS). Inflammatory pathways activated in insulin resistant and diabetic individuals may be partially mediated through kinases, Iκβ kinase-β (IKKβ) and Jun N-terminal kinase (JNK), the IKKβ being an activator of NF-κB. 104, 110 It is recognized that activation of NF-κB is a crucial step for cytokine-stimulated β-cell dysfunction and pathogenesis of T1D. [111] [112] [113] [114] [115] Furthermore, JNK and NF-κB can be activated by cytokines produced in response to their activation, such as IL-1β and TNFα, a feed-forward response.
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It is well established that obesity is a major risk factor for T2D. Interestingly, recent studies reported that a number of genes involved in energy metabolism and glucose homeostasis are regulated by DNA methylation and are altered during obesity. 116 Recent studies utilized a reverse genetics approach to understand the effects of a histone demethylase, Jhdm2a [Jumonji C (JmjC)-domain-containing protein], on energy metabolism and predisposition to obesity and metabolic syndrome. 117, 118 Jhdm2a specifically demethylates H3K9me1 and H3K9me2. 119 Methylation at H3K9 is associated with heterochromatin (transcriptional silencing). Mice lacking this gene were prone to obesity associated with decreased expression of PPARα in skeletal muscle, coupled to decreases in β-oxidation and glycerol release, indicating a reduction in fat oxidation. 118 There was also a decrease in expression of uncoupling protein-1 and PPARα in brown fat, coupled to accumulation of lipid droplets and dampened adaptive disease processes. Without detailed characterization of physiological as well as pathological pattern of epigenetic modifications in specific tissues, it would be impossible to identify epigenetic alterations that are causative and specific to disease process, which however, is essential for developing innovative epigeneticsbased therapies for diabetes.
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Conclusion
Epigenetic modifications are an important form of gene regulation that influences normal growth, development and health. There is mounting evidence to support an epigenetic link to a number of human diseases and evidence to suggest that these changes are heritable. The plasticity of epigenetic regulation and influence by nutritional status and environmental changes points to the importance of understanding the effects of lifestyle factors on molecular changes that influence health. DNA methylation, histone modifications and non-coding RNAs are most studied in the context of individual gene regulation and disease models and may provide an important insight into disease pathogenesis that cannot be explained by genetics. Mapping the epigenome using various high-throughput technologies such as massively parallel sequencing in combination with bisulfite conversion and RNA profiling will greatly facilitate a comprehensive understanding of the roles of epigenetic modifications in normal physiology and
